THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI LAUNCHES EBOLA+ PROGRAMME
IMI has launched an ambitious programme to accelerate the development of vaccines and treatments against Ebola and related diseases. The first Call under the Ebola+ programme has a total budget of €280m.
- 28/11/2014 : RT @VHIR_: VHIR and the Innovative Medicine Initiative presented the future call for proposals http://t.co/oAtgHabWhw @IMI_JU
- 28/11/2014 : RT @eupatients: #FF our EUPATI National Platforms in Spain @EUPATI_Esp UK @EUPATI_UK Switzerland @EUPATI_CH UK @EUPATI_LUX Italy @EUPATI_I…
- 28/11/2014 : RT @PROTECT_BR: Visual communication of #BenefitRisk of #obesity interventions for #weightloss in the #obese. http://t.co/jQxJp6qxUT http:/…